- Home
- RGLS vs BDMD Comparison
RGLS vs BDMD Comparison
Compare RGLS & BDMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGLS
- BDMD
- Stock Information
- Founded
- RGLS 2007
- BDMD 2012
- Country
- RGLS United States
- BDMD China
- Employees
- RGLS N/A
- BDMD N/A
- Industry
- RGLS Biotechnology: Pharmaceutical Preparations
- BDMD
- Sector
- RGLS Health Care
- BDMD
- Exchange
- RGLS Nasdaq
- BDMD NYSE
- Market Cap
- RGLS 102.1M
- BDMD 106.4M
- IPO Year
- RGLS 2012
- BDMD N/A
- Fundamental
- Price
- RGLS $1.55
- BDMD $6.70
- Analyst Decision
- RGLS Strong Buy
- BDMD
- Analyst Count
- RGLS 6
- BDMD 0
- Target Price
- RGLS $10.33
- BDMD N/A
- AVG Volume (30 Days)
- RGLS 268.2K
- BDMD 5.0M
- Earning Date
- RGLS 11-07-2024
- BDMD 01-01-0001
- Dividend Yield
- RGLS N/A
- BDMD N/A
- EPS Growth
- RGLS N/A
- BDMD 578.78
- EPS
- RGLS N/A
- BDMD 0.43
- Revenue
- RGLS N/A
- BDMD $33,048,249.00
- Revenue This Year
- RGLS N/A
- BDMD N/A
- Revenue Next Year
- RGLS N/A
- BDMD N/A
- P/E Ratio
- RGLS N/A
- BDMD $14.16
- Revenue Growth
- RGLS N/A
- BDMD N/A
- 52 Week Low
- RGLS $1.08
- BDMD $1.05
- 52 Week High
- RGLS $3.79
- BDMD $13.52
- Technical
- Relative Strength Index (RSI)
- RGLS 49.06
- BDMD N/A
- Support Level
- RGLS $1.49
- BDMD N/A
- Resistance Level
- RGLS $1.62
- BDMD N/A
- Average True Range (ATR)
- RGLS 0.11
- BDMD 0.00
- MACD
- RGLS -0.00
- BDMD 0.00
- Stochastic Oscillator
- RGLS 37.50
- BDMD 0.00
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
About BDMD BAIRD MEDICAL INVESTMENT HLDGS LTD
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.